Literature DB >> 4123765

Immunochemical studies to the O-antigens of vibrio cholerae. Partial characterization of an acid-labile antigenic determinant.

J W Redmond, M J Korsch, G D Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4123765     DOI: 10.1038/icb.1973.20

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


× No keyword cloud information.
  8 in total

1.  Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.

Authors:  P A Manning; M W Heuzenroeder; J Yeadon; D I Leavesley; P R Reeves; D Rowley
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

Review 2.  Genetics of Vibrio cholerae and its bacteriophages.

Authors:  A Guidolin; P A Manning
Journal:  Microbiol Rev       Date:  1987-06

3.  Regions of the cloned Vibrio cholerae rfb genes needed to determine the Ogawa form of the O-antigen.

Authors:  R Morona; M S Matthews; J K Morona; M H Brown
Journal:  Mol Gen Genet       Date:  1990-12

4.  Eubacterium saburreum L13 antigen containing a ketohexose as a main sugar constituent.

Authors:  N Skaug; T Hofstad
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Immunological characterization of Vibrio cholerae O:1 lipopolysaccharide, O-side chain, and core with monoclonal antibodies.

Authors:  B Gustafsson; T Holme
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Serotype conversion in Vibrio cholerae O1.

Authors:  U H Stroeher; L E Karageorgos; R Morona; P A Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Porins of Vibrio cholerae: purification and characterization of OmpU.

Authors:  S R Chakrabarti; K Chaudhuri; K Sen; J Das
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

8.  Monoclonal antibodies against Vibrio cholerae lipopolysaccharide.

Authors:  B Gustafsson; A Rosén; T Holme
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.